К основному контенту

Accutane

Accutane

     * Generic Name: isotretinoin
     * Brand Name: Accutane


     * What is isotretinoin?
     * What are the possible side effects of isotretinoin?
     * What is the most important information I should know about
       isotretinoin?
     * What should I discuss with my healthcare provider before taking
       isotretinoin?
     * How should I take isotretinoin?
     * What happens if I miss a dose?
     * What happens if I overdose?
     * What should I avoid while taking isotretinoin?
     * What other drugs will affect isotretinoin?
     * Where can I get more information?

What is isotretinoin?

   Isotretinoin is a form of vitamin A. It reduces the amount of
   oil released by oil glands in your skin, and helps your skin renew
   itself more quickly.

   Isotretinoin is used to treat severe nodular acne that has not
   responded to other treatments, including antibiotics.

   Isotretinoin is available only from a certified pharmacy under a
   special program called iPLEDGE.

   Isotretinoin may also be used for purposes not listed in this
   medication guide.

What are the possible side effects of isotretinoin?

   Get emergency medical help if you have signs of an allergic reaction
   (hives, difficult breathing, swelling in your face or throat) or a
   severe skin reaction (fever, sore throat, burning eyes, skin pain,
   red or purple skin rash with blistering and peeling).

   Stop using isotretinoin and call your doctor at once if you have:
     * problems with your vision or hearing;
     * hallucinations, (see or hearing things that are not real),
       thoughts about suicide or hurting yourself;
     * depressed mood, crying spells, changes in behavior, feeling angry
       or irritable;
     * loss of interest in things you enjoyed before, feeling hopeless or
       guilty;
     * sleep problems, extreme tiredness, trouble concentrating;
     * changes in weight or appetite;
     * a seizure (convulsions), sudden numbness or weakness;
     * muscle weakness, pain in your bones or joints or in your back;
     * severe diarrhea, rectal bleeding, bloody or tarry stools;
     * pale skin, feeling light-headed or short of breath;
     * severe stomach or chest pain, pain when swallowing; or
     * dark urine, or jaundice (yellowing of your skin or eyes).

   Common side effects may include:
     * dryness of your skin, lips, eyes, or nose (you may have
       nosebleeds).

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about isotretinoin?

   Isotretinoin in just a single dose can cause severe birth defects or
   death of a baby. Never use this medicine if you are pregnant or may
   become pregnant.

   You must have a negative pregnancy test before taking isotretinoin.
   You will also be required to use two forms of birth control to prevent
   pregnancy while taking this medicine. Stop using isotretinoin and call
   your doctor at once if you think you might be pregnant.

   Accutane Patient Information including How Should I Take
   Acne:Causes, Solutions and Treatments for Adults

   Adult Acne Slideshow Pictures
   RxList

   Take the Quiz: Test Your Acne IQ
   Skin Health: 15 Tips for Clear Skin

   Helping Your Teen With Acne Slideshow Pictures

What should I discuss with my healthcare provider before taking isotretinoin?

   Isotretinoin can cause miscarriage, premature birth, severe birth
   defects, or death of a baby if the mother takes this medicine at the
   time of conception or during pregnancy. Even one dose of isotretinoin
   can cause major birth defects of the baby's ears, eyes, face,
   skull, heart, and brain. Never use isotretinoin if you are pregnant.

   For Women: Unless you have had your uterus and ovaries removed
   (total hysterectomy) or have been in menopause for at least 12
   months in a row, you are considered to be of child-bearing potential.
   You must have a negative pregnancy test before you start taking
   isotretinoin, before each prescription is refilled, right after you
   take your last dose of isotretinoin, and again 30 days later. All
   pregnancy testing is required by the iPLEDGE program.

   You must agree in writing to use two specific forms of birth control
   beginning 30 days before you start taking isotretinoin and ending 30
   days after your last dose. Both a primary and a secondary form of birth
   control must be used together.

   Primary forms of birth control include:
     * tubal ligation (tubes tied);
     * vasectomy of the male sexual partner;
     * an IUD (intrauterine device);
     * estrogen-containing birth control pills (not mini-pills); and
     * hormonal birth control patches, implants, injections, or vaginal
       ring.

   Secondary forms of birth control include:
     * a male latex condom with or without spermicide;
     * a diaphragm plus a spermicide;
     * a cervical cap plus a spermicide; and
     * a vaginal sponge containing a spermicide.

   Not having sexual intercourse (abstinence) is the most effective method
   of preventing pregnancy.

   Stop using isotretinoin and call your doctor at once if you have
   unprotected sex, if you quit using birth control, if your period is
   late, or if you think you might be pregnant. If you get pregnant while
   taking isotretinoin, call the iPLEDGE pregnancy registry at
   1-866-495-0654.

   You should not use isotretinoin if you are allergic to it.

   Tell your doctor if you have ever had:
     * depression or mental illness;
     * asthma;
     * liver disease;
     * diabetes;
     * heart disease or high cholesterol;
     * osteoporosis or low bone mineral density;
     * an eating disorder such as anorexia;
     * a food or drug allergy; or
     * an intestinal disorder such as inflammatory bowel disease or
       ulcerative colitis.

   It is dangerous to try and purchase isotretinoin on the Internet or
   from vendors outside of the United States. The sale and distribution of
   isotretinoin outside of the iPLEDGE program violates the regulations of
   the U.S. Food and Drug Administration for the safe use of this
   medication.

   You should not breast-feed while using this medicine.

   Isotretinoin is not approved for use by anyone younger than 12 years
   old.

How should I take isotretinoin?

   Follow all directions on your prescription label and read all
   medication guides or instruction sheets. Use the medicine exactly as
   directed.

   Each prescription of isotretinoin must be filled within 7 days of the
   date it was written by your doctor. You will receive no more than a
   30-day supply of isotretinoin at one time.

   Always take isotretinoin with a full glass of water. Do not chew or
   suck on the capsule. Swallow it whole.

   Follow all directions about taking isotretinoin with or without food.

   Use this medicine for the full prescribed length of time. Your acne may
   seem to get worse at first, but should then begin to improve.

   You may need frequent blood tests.

   Never share this medicine with another person, even if they have the
   same symptoms you have.

   Store at room temperature away from moisture, heat, and light.

   Accutane Patient Information including If I Miss a Dose
   Acne:Causes, Solutions and Treatments for Adults

   Adult Acne Slideshow Pictures
   RxList

   Take the Quiz: Test Your Acne IQ
   Skin Health: 15 Tips for Clear Skin

   Helping Your Teen With Acne Slideshow Pictures

What happens if I miss a dose?

   Skip the missed dose and use your next dose at the regular time. Do not
   use two doses at one time.

What happens if I overdose?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222. Overdose symptoms may include headache, dizziness,
   vomiting, stomach pain, warmth or tingling in your face, swollen or
   cracked lips, and loss of balance or coordination.

What should I avoid while taking isotretinoin?

   Do not take a vitamin or mineral supplement that contains vitamin A.

   Do not donate blood while taking isotretinoin and for at least 30 days
   after you stop taking it. Donated blood that is later given to a
   pregnant woman could lead to birth defects in her baby if the blood
   contains any level of isotretinoin.

   While you are taking isotretinoin and for at least 6 months after your
   last dose: Do not use wax hair removers or have dermabrasion or
   laser skin treatments. Scarring may result.

   Isotretinoin could make you sunburn more easily. Avoid sunlight or
   tanning beds. Wear protective clothing and use sunscreen (SPF 30 or
   higher) when you are outdoors.

   Avoid driving or hazardous activity until you know how this medicine
   will affect you. Isotretinoin may impair your vision, especially at
   night.

What other drugs will affect isotretinoin?

   Tell your doctor about all your other medicines, especially:
     * phenytoin;
     * St. John's wort;
     * vitamin or mineral supplements;
     * progestin-only birth control pills (mini-pills);
     * steroid medicine; or
     * a tetracycline antibiotic, including doxycycline or
       minocycline.

   This list is not complete. Other drugs may affect isotretinoin,
   including prescription and over-the-counter medicines, vitamins, and
   herbal products. Not all possible drug interactions are listed here.

Where can I get more information?

   Your pharmacist can provide more information about isotretinoin.
     __________________________________________________________________


Комментарии

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...